All about COVID-19

No evidence to suggest coronavirus cluster 5 variant found in minks increases virus transmissibility, disease severity

Denmark had on November 6 ordered culling of the entire farmed mink population of 17 million to prevent further changes to the virus emerging among minks.   | Photo Credit: AFP

Since June, 214 people in Denmark have been reported to have been infected with a variant of the novel coronavirus associated with farmed minks. This includes 12 cases reported on November 5 in people aged 7-79 years who had a link with mink farming; four cases were through human-to-human transmission of the variant. So far, six countries — Denmark, the Netherlands, Spain, Sweden, Italy and the U.S. — have reported SARS-CoV-2 in farmed minks, the World Health Organization (WHO) says.

Also Read | WHO urges dexamethasone boom for worst virus cases

The variant called “cluster 5” has a combination of mutations not seen previously. Cluster 5 makes up around 5% of the strains found in northern Denmark. So far, this variant has not been reported from other countries, suggesting that the variant has not spread beyond Denmark.

Denmark had on November 6 ordered culling of the entire farmed mink population of 17 million to prevent further changes to the virus emerging among minks, and the spread of mink-related viruses any more from minks to humans.

Significance of the variant

According to the WHO, initial observations suggest that the “clinical presentation, severity and transmission among those infected are similar to that of other circulating SARS-CoV-2 viruses”. It further added: “The implications of the identified changes in this variant are not yet well understood. Preliminary findings indicate that this particular mink-associated variant identified in both minks and the 12 human cases has moderately decreased sensitivity to neutralizing antibodies.”

Denmark epidemiologist Kare Molbak said cluster 5 was not more dangerous than other strains or more infectious, according to Reuters.

Also Read | Explainer: What is the D614G mutation in coronavirus?

“Scientists have not yet noted changes to the mink-related strain of the virus identified in Denmark that affect transmissibility, disease severity or reinfection in people. But further evidence is needed,” WHO tweeted. Further studies are needed to understand the significance of the variant in terms of diagnostics, therapeutics and vaccines in development.

Prof. Francois Balloux, Director of UCL Genetics Institute, U.K. said in a tweet that his colleagues had previously identified mutations in the virus, including one in the Spike protein, occurred repeatedly in minks, which may be involved in increased transmission in carnivore hosts.

Prof. Balloux further said: “SARS-CoV-2 mutations acquired in minks are not concerning. We already knew that SARS-CoV-2 can transmit from minks to humans. Though, this should be of no concern in terms of the evolution of the transmissibility of the virus.”

Also Read | The Hindu Explains: What are the long-term effects of COVID-19?

In a tweet thread, Prof. Balloux explained that the variant seen in mink, which has also spread to humans, may not increase the ability of the virus to spread. “The population of SARS-CoV-2 is so large that any mutation viable to the virus has arisen many times by now. There is no evidence that any such mutation affects transmissibility in humans (with the possible, questionable exception of D614G),” he noted. “There are thousands of mutations in SARS-CoV-2 arising constantly. The fact that a few have been observed in minks will not change the strains in circulation in humans. If they were beneficial for the virus to infect its human host, they would be at high frequency already.”

Impact on vaccine efficacy

“We need to wait and see what the implications are but I don’t think we should come to any conclusions about whether this particular mutation is going to impact vaccine efficacy,” says WHO’s Chief Scientist Dr. Soumya Swaminathan. “We don’t have any evidence at the moment that it would.”

Prof. Balloux has been more critical of news reports suggesting that the variant might impact vaccine efficacy. “The ‘vaccine escape’ scare story is just idiotic. Vaccine-escape mutations may (or not) arise in humans in the future, if they are advantageous to the virus for (once vaccines will be deployed). They definitely won’t be fuelled by mutations having emerged in minks,” he tweeted.

Also Read | One mutated coronavirus type dominates globally

Jumping across species

The virus had jumped to minks from humans infected with SARS-CoV-2. Mink and humans have a similar biological trait regarding a so-called ACE2-enzyme expressed by cells of the respiratory tract, which makes it easier for mink to be infected with a virus that has adapted to humans, Allan Randrup Thomsen, a virologist at Copenhagen University, told Reuters.

“Minks can act as a reservoir of SARS-CoV-2, passing the virus between them, and pose a risk for virus spill-over from mink to humans. People can then transmit this virus within the human population. Additionally, spill-back (human to mink transmission) can occur,” the WHO says.

Also Read | Virus mutations unlikely to mean stronger strain: experts

“That is a concern because mammal species like mink are very good hosts and the virus can evolve within those species especially if they are in large numbers packed closely together,” Mike Ryan of WHO says.

“It is normal for viruses to mutate or change over time. But each time a virus goes from humans to animals and back to humans, it can change more. That’s why these reports are concerning,” WHO tweeted.

Four of the latest 12 people who were from the local community already indicates the ability of the variant to spread from one person to another.

Also Read | Almost a third of COVID-19 samples show mutation, but not worse disease, says WHO

Animals getting infected with SARS-CoV-2 remain a concern as the infected animals could contribute to amplifying and spreading the virus. While mutations arise even when the virus spreads amongst humans, genetic modifications in the virus not seen so far can occur when the virus jumps from humans to animals and back to humans, as seen now.

The spread of the variant from mink to humans “highlights the important role that farmed mink populations can play in the ongoing transmission of SARS-CoV-2 and the critical role of strong surveillance, sampling and sequencing SARS-CoV-2, especially around areas where such animal reservoirs are identified,” the WHO noted.

Our code of editorial values

Related Topics
This article is closed for comments.
Please Email the Editor

Printable version | Oct 25, 2021 1:58:31 PM |

In This Package
The Hindu Explains | How is India preparing to roll out COVID-19 vaccines?
The Hindu Explains | Why was a COVID-19 vaccine dry run necessary, and how was it organised?
Coronavirus | Why people with prior infection still need COVID-19 vaccination
Explained | What we know about China-made vaccines
How infections among participants are a part of vaccine trials | The Hindu In Focus podcast
The Hindu Explains | What is emergency use authorisation for drugs and vaccines?
Coronavirus | How the new variant quickly accumulated 23 mutations
Coronavirus | New variant does not increase reinfection risk, disease severity, deaths
Coronavirus | N501Y mutation in SARS-CoV-2 virus causes increased infectivity in mice: researchers
The Hindu Explains | Are viruses expected to change form, and will vaccines protect against a mutating SARS-CoV-2?
Coronavirus | Is the first wave coming to an end in India?
Has India passed the COVID-19 peak? | The Hindu Parley podcast
Has India passed its COVID-19 peak, as a new government study claims? | The Hindu In Focus podcast
You are reading
No evidence to suggest coronavirus cluster 5 variant found in minks increases virus transmissibility, disease severity
SARS-CoV-2 not the last virus to spark a pandemic, says expert
The Hindu Explains | Who are the top contenders in the race for a COVID-19 vaccine?
The vaccine networks India will rely on and the challenges ahead | The Hindu In Focus podcast
Study advances use of indomethacin for treatment of mild cases
How an asymptomatic player turned super-spreader
How close are we to getting a COVID-19 vaccine? | The Hindu In Focus podcast
WHO warns against pursuing herd immunity to stop coronavirus
Studies document in-flight transmission of coronavirus
Experimental study finds how coronavirus can spread while speaking
Can universal masking be a crude ‘vaccine’?
The Hindu Explains | Is COVID-19 setting off a bradykinin storm in the body?
Coronavirus | Lung damage in COVID-19 dead may shed light on ‘long COVID’: study
The Hindu Explains | What does herd immunity mean for COVID-19?
The Hindu Explains | What do we know about Russia’s COVID-19 vaccine candidate Sputnik V?
Coronavirus | Russian vaccine generated strong immune response, says Lancet study
Watch | Is COVID-19 intensifying in rural India?
The Hindu Explains | Why is Phase-3 of COVID-19 vaccine trial complicated?
The Hindu Explains | What are the long-term effects of COVID-19?
The Hindu Explains | Are there re-infection fears around COVID-19?
Watch | COVID-19 and children
The Hindu Explains | Is SARS-CoV-2 a latent virus which can recur?
Watch | What is an immunity passport?
WHO says COVID-19 by far its worst global health emergency
CDC says revised guidance on coronavirus spread posted in error, removes it
Coronavirus | Plasma therapy may look promising in treating COVID-19, but it is no magic bullet
Coronavirus | Different kinds of SARS-CoV-2 exist in India but none more lethal than the other: Indian Academy of Sciences President
The Hindu Explains | Is airborne transmission of COVID-19 a risk?
Watch | What are serological surveys?
The Hindu Explains | Why is a psoriasis drug being used to treat COVID-19 patients?
Video: In conversation with Andrew Pollard, Director of Oxford Vaccine Group
Watch | All you need to know about pulse oximeters
Coronavirus | Why are only a fraction of cases tested?
Coronavirus | Vaccine was rapidly synthesised as novel coronavirus sequence was available, says virologist Gagandeep Kang
A step closer to developing a potent drug against novel coronavirus
Coronavirus | The importance of ‘contact tracing’
Coronavirus | Are diabetics more prone to COVID-19?
Private firms ready to test for COVID-19
Coronavirus | How does soap use help in tackling COVID-19?
Fight for the finite: On budgetary allocation for health
Coronavirus | A problematic testing strategy
Fighting COVID-19 together for a shared future
Scientists get ready to test rival COVID-19 pandemic vaccines in animals
Coronavirus | The cost of opacity
Watch | COVID-19: Masks and sanitisers are now essential commodities
A COVID-19 control plan made simple
Watch | Your COVID-19 queries answered
Coronavirus | How is India containing COVID-19?
Battle against COVID-19
Watch | COVID-19: Dos and don'ts from the Health Ministry
A COVID-19 response that is quick off the blocks
Watch | Why is COVID-19 not a pandemic yet?
Watch | Coronavirus: Can masks protect you?
Watch | How is India dealing with coronavirus?
WHO’s unexplained hesitancy
Watch | Bats and the novel coronavirus
Coronavirus | India shares two SARS-CoV-2 genome sequences
COVID-19 | We are in uncharted territory, says WHO
Explained | Why is COVID-19 not a pandemic yet?
New COVID-19 epidemic at ‘decisive point’: WHO chief
COVID-19 vaccine may be ready by 2022: SII
Explainer: How WHO names a new disease
WHO names deadly viral disease from China as 'COVID-19'
Explained | When can people transmit the novel coronavirus?
Analysis | For China’s Xi, the coronavirus challenge comes laden with economic costs and political risks
How bats harbour several viruses yet not get sick
WHO declares coronavirus outbreak a global emergency
Watch | What is Coronavirus?
What is the source of the new SARS-like disease reported in China?
Data | The wide, rapid spread of the novel coronavirus
Alarming spread: on novel coronavirus outbreak
Gaps in our knowledge of coronavirus origin need fulfilment: Study
A new virus emerges in China
Next Story